CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 1 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | -16.7% | 3,005 | -26.3% | 0.00% | – |
| Q4 2021 | $12,000 | -25.0% | 4,075 | -1.1% | 0.00% | – |
| Q3 2021 | $16,000 | +700.0% | 4,120 | +951.0% | 0.00% | – |
| Q2 2021 | $2,000 | -50.0% | 392 | +21.4% | 0.00% | – |
| Q1 2021 | $4,000 | -92.7% | 323 | -91.4% | 0.00% | – |
| Q4 2020 | $55,000 | +511.1% | 3,750 | +400.0% | 0.00% | – |
| Q3 2020 | $9,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 0 | $0 | 0.00% |